MEU

www.meu.org.uk/ www.linkedin.com/company/medicines-evaluation-unit/

Medicines Evaluation Unit (MEU) Ltd is one of the UK’s leading CROs, a facility where commitment to excellence is paramount. MEU possess extensive pharmaceutical, scientific and clinical expertise, allied with fast volunteer recruitment, within a state-of-the-art hospital-based research facility.

MEU offer products and services to enable better, safer and more efficient study designs, particularly in complex patient groups. MEU’s bespoke, phenotyped database and trial management system (ICARUS), assists rapid study recruitment ensuring we meet our clients’ timelines. ICARUS possesses over 32,000 active volunteer profiles and enables MEU to assess protocol inclusion criteria, and accurately provide real-time feasibility.

MEU has a team of experienced Principal Investigators led by the worldrenowned respiratory KOL Professor Dave Singh, MEU Medical Director. To accelerate drug discovery, MEU have a host of human lung tissue models for target identification and validation studies. The techniques used include cell culture, immunoassays, immunohistochemistry, PCR and flow cytometry.

The majority of our studies are Phase I – III (inc. FIH & FIP), in both healthy volunteers and the following therapeutic areas:

• Respiratory (Asthma, COPD, Cough, CF, ILD/IPF)

• Dermatology (AD, Psoriasis, Urticaria)

• Endocrine (Graves’)

• Cardiovascular (Hypertension

• Renal (CKD)

David Rogers

Chief Executive Officer, MEU

+44 798 000 0037 drogers@meu.org.uk

Liz Batty

Clinical Director

+44 796 602 1717 lbatty@meu.org.uk